Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene (ENSG00000259665) is a pseudogene, a genomic DNA segment that structurally resembles a protein-coding gene—specifically related to the PTEN family—but has lost its ability to encode a functional protein due to disabling mutations[5][3]. Pseudogenes, including this one, are generally nonfunctional in terms of protein synthesis and are excluded from drug target lists. However, in some cases, pseudogenes may modulate gene expression of their parent gene through non-coding RNA mechanisms, serving as regulatory elements such as miRNA sponges or competing endogenous RNA[3]. This locus is not considered a therapeutic target or receptor, lacks protein expression, and does not directly interact with drugs. It is best classified as a pseudogene with possible regulatory functions in gene expression, but it is not directly involved in canonical biological pathways or disease mechanisms as an active molecule[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene.